In situ cytokine therapy: Redistribution of clonally expanded T cells

European Journal of Immunology

Volumn 31, Issue 1, 2001, Pages 250-258

  Straten, Per thor ^a   Guldberg, Per ^a   Schrama, David ^b   Andersen, Mads Hald ^a   Moerch, Ulrik ^a   Seremet, Tina ^a   Siedel, Claudia ^b   Reisfeld, Ralph A ^c   Becker, Jürgen C ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Clonal expansion; Cytokine; Recirculation; Recruitment; T cell receptor; T lymphocyte

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; CYTOKINE RELEASE; GENE TARGETING; IMMUNOTHERAPY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BASE SEQUENCE; HUMANS; INTERLEUKIN-2; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0035133594     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200101)31:1<250::AID-IMMU250>3.0.CO;2-8     Document Type: Article

References (25)

1. Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review
2. Paracrine cytokine adjuvants in cancer immunotherapy
3. A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring
4. Antibody-targeted interleukin stimulates T-cell killing of autologous tumour cells
5. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by an antibodyinterleukin 2 fusion proteins
6. T-cell mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 theray
7. Activation of pre-existing T-cell clones by targeted interleukin 2 therapy
8. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction
9. Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy
10. Detection and characterization of alpha/beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE)
11. In situ T-cell responses against melanoma comprise high numbers of locally expanded T-cell clonotypes
12. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis
13. An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response
14. Escape from host-antitumor immunity
15. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100
16. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
17. Characterization of B16 melanoma-specific cytotoxic T lymphocytes
18. Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination
19. Comparative delineation of T cell clonotypes in coexisting syngeneic B 16 melanoma
20. Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies
21. Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8- sialyltransferase cDNA using anti-GD2 monoclonal antibody
22. Autoradiography using storage phosphor technology
23. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes
24. 'Broad-range' DGGE for single-step mutation scanning of entire genes: Application to human phenylalanine hydroxylase gene